Separating politics and scientific research on heroin prescription

Alex D Wodak, Alison J Ritter and Charles RR Watson
Med J Aust 2002; 176 (10): . || doi: 10.5694/j.1326-5377.2002.tb04510.x
Published online: 6 May 2002

To the Editor: Hall et al1 argue that a hydromorphone trial would break the current deadlock in Australia over prescription heroin research. But would it? If hydromorphone was demonstrated to be an effective intervention for treating refractory heroin users, researchers would then wish to compare both hydromorphone and prescription heroin against the gold standard, oral methadone.

  • Alex D Wodak
  • Alison J Ritter
  • Charles RR Watson

  • 1 Alcohol and Drug Service, St Vincent's Hospital, Darlinghurst, NSW.
  • 2 Turning Point Alcohol and Drug Research Centre Inc., Fitzroy, VIC.
  • 3 Health Sciences, Curtin University, Perth, WA.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.